Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kidney yang deficiency (KYD) is a systemic syndrome in Traditional Chinese Medicine (TCM) that describes a state of metabolic and endocrine hypofunction, rather than a single molecular target. It is characterized by the depletion of Yang energy, which is responsible for warming, transformation, and activation within the body. Modern research identifies KYD as a multi-systemic disorder involving the dysregulation of the neuroendocrine-immune (NEI) network, particularly the hypothalamic-pituitary-adrenal (HPA), hypothalamic-pituitary-gonadal (HPG), and hypothalamic-pituitary-thyroid (HPT) axes (Shen et al., 2011, PubMed). Clinical manifestations include cold intolerance, fatigue, and sexual dysfunction, which are treated using herbal formulas like Jin-Gui-Shen-Qi-Wan that aim to restore hormonal and metabolic homeostasis. Pharmacological studies suggest these interventions act by modulating cyclic nucleotide levels (cAMP/cGMP ratio) and enhancing mitochondrial energy production (Zhao et al., 2013, Journal of Ethnopharmacology). This syndrome is often used as a model for studying the biological basis of TCM patterns and their response to multi-component herbal therapies.
Modulation of the Hypothalamic-Pituitary-Adrenal (HPA), Hypothalamic-Pituitary-Gonadal (HPG), and Hypothalamic-Pituitary-Thyroid (HPT) axes to restore metabolic and thermal homeostasis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kidney yang deficiency (KYD) (KYD).